Scott Hutson

Scott Hutson's work experience includes holding the position of Vice President of Sales at Geron Corporation since November 2022. Prior to that, they worked at AstraZeneca as the Sr. Commercial Business Director for AstraZeneca Oncology - Lung Cancer from March 2015 to November 2022. Before AstraZeneca, they served as the Area Business Director for Medivation from March 2012 to March 2015, where they were involved in the launch of the prostate cancer drug Xtandi. Scott also worked as the Senior Director of Sales & Marketing at Metagenics from June 2010 to March 2012 and as the Senior Sales Director of Oncology at Johnson & Johnson from July 1999 to June 2010. Scott began their career at Bristol-Myers Squibb as a Regional Trainer for Cardiovascular & Metabolic's from July 1997 to July 1999.

Scott Hutson attended Arizona State University, where they pursued degrees in both Political Science and Business. However, no specific information regarding the start or end years of their education at this institution is provided.